| Product Code: ETC7355835 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Pediatric Vaccines Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Pediatric Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Pediatric Vaccines Market - Industry Life Cycle |
3.4 Greece Pediatric Vaccines Market - Porter's Five Forces |
3.5 Greece Pediatric Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Greece Pediatric Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Greece Pediatric Vaccines Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Greece Pediatric Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of pediatric vaccination in preventing diseases |
4.2.2 Government initiatives to promote vaccination programs and increase accessibility |
4.2.3 Growing focus on research and development for innovative pediatric vaccines |
4.3 Market Restraints |
4.3.1 High cost associated with pediatric vaccines and vaccination programs |
4.3.2 Vaccine hesitancy among some parents or caregivers |
4.3.3 Regulatory challenges and approval processes for new vaccines |
5 Greece Pediatric Vaccines Market Trends |
6 Greece Pediatric Vaccines Market, By Types |
6.1 Greece Pediatric Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Greece Pediatric Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Greece Pediatric Vaccines Market Revenues & Volume, By Monovalent, 2021- 2031F |
6.1.4 Greece Pediatric Vaccines Market Revenues & Volume, By Multivalent, 2021- 2031F |
6.2 Greece Pediatric Vaccines Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Greece Pediatric Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021- 2031F |
6.2.3 Greece Pediatric Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.2.4 Greece Pediatric Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.2.5 Greece Pediatric Vaccines Market Revenues & Volume, By Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, 2021- 2031F |
6.3 Greece Pediatric Vaccines Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Greece Pediatric Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3.3 Greece Pediatric Vaccines Market Revenues & Volume, By Human Papilloma Virus, 2021- 2031F |
6.3.4 Greece Pediatric Vaccines Market Revenues & Volume, By Measles, Mumps and Rubella, 2021- 2031F |
6.3.5 Greece Pediatric Vaccines Market Revenues & Volume, By Meningococcal Disease, 2021- 2031F |
6.3.6 Greece Pediatric Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.3.7 Greece Pediatric Vaccines Market Revenues & Volume, By Polio, 2021- 2031F |
6.3.8 Greece Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
6.3.9 Greece Pediatric Vaccines Market Revenues & Volume, By Diphtheria, Pertussis and Tetanus, 2021- 2031F |
7 Greece Pediatric Vaccines Market Import-Export Trade Statistics |
7.1 Greece Pediatric Vaccines Market Export to Major Countries |
7.2 Greece Pediatric Vaccines Market Imports from Major Countries |
8 Greece Pediatric Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rate among children in Greece |
8.2 Number of government-funded vaccination campaigns for pediatric vaccines |
8.3 Research and development investment in pediatric vaccines by pharmaceutical companies |
8.4 Percentage of pediatric population covered under national vaccination programs |
8.5 Adverse events following immunization (AEFI) reporting rate |
9 Greece Pediatric Vaccines Market - Opportunity Assessment |
9.1 Greece Pediatric Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Greece Pediatric Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Greece Pediatric Vaccines Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Greece Pediatric Vaccines Market - Competitive Landscape |
10.1 Greece Pediatric Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Greece Pediatric Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here